BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Strauss BS. Hypermutability in Carcinogenesis. Genetics 1998;148:1619-26. [DOI: 10.1093/genetics/148.4.1619] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Ilyas M, Straub J, Tomlinson IP, Bodmer WF. Genetic pathways in colorectal and other cancers. Eur J Cancer. 1999;35:335-351. [PMID: 10448282 DOI: 10.1016/s0959-8049(99)00298-1] [Cited by in Crossref: 101] [Cited by in F6Publishing: 44] [Article Influence: 4.4] [Reference Citation Analysis]
2 Nozawa H, Oda E, Nakao K, Ishihara M, Ueda S, Yokochi T, Ogasawara K, Nakatsuru Y, Shimizu S, Ohira Y, Hioki K, Aizawa S, Ishikawa T, Katsuki M, Muto T, Taniguchi T, Tanaka N. Loss of transcription factor IRF-1 affects tumor susceptibility in mice carrying the Ha-ras transgene or nullizygosity for p53. Genes Dev 1999;13:1240-5. [PMID: 10346812 DOI: 10.1101/gad.13.10.1240] [Cited by in Crossref: 95] [Cited by in F6Publishing: 89] [Article Influence: 4.1] [Reference Citation Analysis]
3 Lamolle G, Marin M, Alvarez-Valin F. Silent mutations in the gene encoding the p53 protein are preferentially located in conserved amino acid positions and splicing enhancers. Mutat Res 2006;600:102-12. [PMID: 16650445 DOI: 10.1016/j.mrfmmm.2006.03.004] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
4 Strauss BS. Frameshift mutation, microsatellites and mismatch repair. Mutation Research/Reviews in Mutation Research 1999;437:195-203. [DOI: 10.1016/s1383-5742(99)00066-6] [Cited by in Crossref: 40] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
5 Wilson VL. Detecting Rare Mutations Associated with Cancer Risk: . American Journal of PharmacoGenomics 2001;1:283-93. [DOI: 10.2165/00129785-200101040-00005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
6 Zhang S, Lloyd R, Bowden G, Glickman BW, de Boer JG. Msh2 deficiency increases the mutation frequency in all parts of the mouse colon. Environ Mol Mutagen 2002;40:243-50. [PMID: 12489114 DOI: 10.1002/em.10113] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
7 Hara T, Kouno J, Nakamura K, Kusaka M, Yamaoka M. Possible role of adaptive mutation in resistance to antiandrogen in prostate cancer cells. Prostate 2005;65:268-75. [DOI: 10.1002/pros.20282] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 1.3] [Reference Citation Analysis]
8 Rodin SN, Rodin AS. Strand asymmetry of CpG transitions as indicator of G1 phase-dependent origin of multiple tumorigenic p53 mutations in stem cells. Proc Natl Acad Sci U S A 1998;95:11927-32. [PMID: 9751767 DOI: 10.1073/pnas.95.20.11927] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 1.2] [Reference Citation Analysis]
9 Michor F, Iwasa Y, Nowak MA. Dynamics of cancer progression. Nat Rev Cancer 2004;4:197-205. [PMID: 14993901 DOI: 10.1038/nrc1295] [Cited by in Crossref: 268] [Cited by in F6Publishing: 218] [Article Influence: 14.9] [Reference Citation Analysis]
10 Komarova NL, Sengupta A, Nowak MA. Mutation–selection networks of cancer initiation: tumor suppressor genes and chromosomal instability. Journal of Theoretical Biology 2003;223:433-50. [DOI: 10.1016/s0022-5193(03)00120-6] [Cited by in Crossref: 141] [Cited by in F6Publishing: 60] [Article Influence: 7.4] [Reference Citation Analysis]
11 Frank SA, Nowak MA. Problems of somatic mutation and cancer. Bioessays. 2004;26:291-299. [PMID: 14988930 DOI: 10.1002/bies.20000] [Cited by in Crossref: 81] [Cited by in F6Publishing: 64] [Article Influence: 4.5] [Reference Citation Analysis]
12 Rodin SN, Rodin AS, Juhasz A, Holmquist GP. Cancerous hyper-mutagenesis in p53 genes is possibly associated with transcriptional bypass of DNA lesions. Mutat Res 2002;510:153-68. [PMID: 12459451 DOI: 10.1016/s0027-5107(02)00260-9] [Cited by in Crossref: 23] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
13 Kivisaar M. Stationary phase mutagenesis: mechanisms that accelerate adaptation of microbial populations under environmental stress. Environ Microbiol 2003;5:814-27. [PMID: 14510835 DOI: 10.1046/j.1462-2920.2003.00488.x] [Cited by in Crossref: 56] [Cited by in F6Publishing: 51] [Article Influence: 3.1] [Reference Citation Analysis]
14 Ilyas M, Straub J, Tomlinson IP, Bodmer WF. Genetic pathways in colorectal and other cancers. Eur J Cancer. 1999;35:335-351. [PMID: 10448282 DOI: 10.1016/s0959-8049(98)00431-6] [Cited by in Crossref: 100] [Cited by in F6Publishing: 21] [Article Influence: 4.3] [Reference Citation Analysis]
15 Shin CY, Mellon I, Turker MS. Multiple mutations are common at mouse Aprt in genotoxin-exposed mismatch repair deficient cells. Oncogene 2002;21:1768-76. [DOI: 10.1038/sj.onc.1205241] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 0.8] [Reference Citation Analysis]
16 Nunney L. Lineage selection and the evolution of multistage carcinogenesis. Proc Biol Sci 1999;266:493-8. [PMID: 10189713 DOI: 10.1098/rspb.1999.0664] [Cited by in Crossref: 135] [Cited by in F6Publishing: 97] [Article Influence: 5.9] [Reference Citation Analysis]
17 Michor F, Iwasa Y. Dynamics of metastasis suppressor gene inactivation. J Theor Biol 2006;241:676-89. [PMID: 16497335 DOI: 10.1016/j.jtbi.2006.01.006] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
18 López M, Aguirre JM, Cuevas N, Anzola M, Videgain J, Aguirregaviria J, Castro A, de Pancorbo MM. Use of cytological specimens for p53 gene alteration detection in oral squamous cell carcinoma risk patients. Clin Oncol (R Coll Radiol) 2004;16:366-70. [PMID: 15341441 DOI: 10.1016/j.clon.2004.03.011] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
19 Courtemanche C, Anderson A. Multiple mutations in a shuttle vector modified by ultraviolet irradiation, (+/-)-7 beta,8 alpha-dihydroxy-9 alpha,10 alpha-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene, and aflatoxin B(1) have different properties than single mutations and may be generated during translesion synthesis. Mutat Res 1999;430:23-36. [PMID: 10592315 DOI: 10.1016/s0027-5107(99)00113-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
20 Harfe BD, Jinks-Robertson S. DNA polymerase zeta introduces multiple mutations when bypassing spontaneous DNA damage in Saccharomyces cerevisiae. Mol Cell 2000;6:1491-9. [PMID: 11163221 DOI: 10.1016/s1097-2765(00)00145-3] [Cited by in Crossref: 93] [Cited by in F6Publishing: 64] [Article Influence: 4.4] [Reference Citation Analysis]
21 Yang K, Lindblad P, Egevad L, Hemminki K. Novel somatic mutations in the VHL gene in Swedish archived sporadic renal cell carcinomas. Cancer Letters 1999;141:1-8. [DOI: 10.1016/s0304-3835(99)00031-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
22 Coleman WB, Tsongalis GJ. Molecular mechanisms of human carcinogenesis. EXS 2006;:321-49. [PMID: 16383025 DOI: 10.1007/3-7643-7378-4_14] [Cited by in Crossref: 5] [Cited by in F6Publishing: 15] [Article Influence: 0.3] [Reference Citation Analysis]
23 Strauss BS. Role in tumorigenesis of silent mutations in the TP53 gene. Mutat Res 2000;457:93-104. [PMID: 11106801 DOI: 10.1016/s0027-5107(00)00135-4] [Cited by in Crossref: 21] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
24 Keohavong P, Gao WM, Mady HH, Kanbour-Shakir A, Melhem MF. Analysis of p53 mutations in cells taken from paraffin-embedded tissue sections of ductal carcinoma in situ and atypical ductal hyperplasia of the breast. Cancer Lett 2004;212:121-30. [PMID: 15246568 DOI: 10.1016/j.canlet.2004.03.010] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
25 Ragnarsson-Olding BK, Karsberg S, Platz A, Ringborg UK. Mutations in the TP53 gene in human malignant melanomas derived from sun-exposed skin and unexposed mucosal membranes. Melanoma Res 2002;12:453-63. [PMID: 12394187 DOI: 10.1097/00008390-200209000-00007] [Cited by in Crossref: 43] [Cited by in F6Publishing: 32] [Article Influence: 2.3] [Reference Citation Analysis]
26 Baross-francis A, Milhausen M, Andrew SE, Jevon G, Jirik FR. Tumors arising in DNA mismatch repair-deficient mice show a wide variation in mutation frequency as assessed by a transgenic reporter gene. Carcinogenesis 2000;21:1259-62. [DOI: 10.1093/carcin/21.6.1259] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
27 Jung IL, Kim IG. Polyamine as a signaling molecule for controlling an adaptive mutation. Biochemistry (Mosc) 2008;73:1228-34. [PMID: 19120027 DOI: 10.1134/s0006297908110096] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
28 Iwasa Y, Michor F, Komarova NL, Nowak MA. Population genetics of tumor suppressor genes. Journal of Theoretical Biology 2005;233:15-23. [DOI: 10.1016/j.jtbi.2004.09.001] [Cited by in Crossref: 49] [Cited by in F6Publishing: 33] [Article Influence: 2.9] [Reference Citation Analysis]